Siltuximab Monoclonal Antibody Drug. Targets Interleukin-6 Receptor And Is Approved For The Treatment Of Rheumatoid Arthritis. Royalty-Free Stock Photography
Siltuximab monoclonal antibody drug. Targets interleukin-6 receptor and is approved for the treatment of rheumatoid arthritis. #186809975
Description
Siltuximab monoclonal antibody drug. Targets interleukin-6 receptor and is approved for the treatment of rheumatoid arthritis. Generic name and stylized antibody representation